— Know what they know.
Not Investment Advice
Also trades as: TRLV (NYSE) · $vol 17M · TRUL.CN (CNQ) · $vol 3M

TCNNF OTC

Trulieve Cannabis Corp.
1W: +5.3% 1M: +23.9% 3M: +26.7% YTD: +40.8% 1Y: +37.6% 3Y: +227.5% 5Y: -55.2%
$12.25
-0.02 (-0.16%)
 
OTC · Healthcare · Drug Manufacturers - Specialty & Generic · Tech Score Buy · Power 67 · $2.4B mcap · 168M float · 1.06% daily turnover · Short 36% of daily vol

Cash Flow Trends

Operating Cash Flow
$278M +2.3% ▲
5Y CAGR: +22.7%
Capital Expenditures
$45M +63.0% ▲
5Y CAGR: -21.1%
Free Cash Flow
$233M +55.1% ▲
Dividends Paid
$0 +100.0% ▲
Buybacks
$0 +0.0% ▲
Net Change in Cash
$16M -51.1% ▼

Cash Flow Composition

Year-over-Year Growth

View Full Cash Flow Statement
Line ItemFY2021FY2022FY2023FY2024FY2025
— Operating Activities —
Net Income$17M-$253M-$533M-$161M-$113M
Depreciation & Amort.$78M$186M$181M$178M$176M
Stock-Based Comp.$9M$18M$11M$20M$0
Change in Working Capital-$85M-$56M$174M$235M$197M
Other Non-Cash Items$19M$155M$387M$9M$35M
Operating Cash Flow$13M$23M$202M$271M$278M
— Investing Activities —
Capital Expenditures-$306M-$185M-$40M-$122M-$62M
Acquisitions (Net)$43M-$26M$977K$0$0
Investment Purchases-$4M-$9M$0-$80M$0
Investment Sales$46M$0$0$20M$61M
Other Investing$5M$4M$2M-$25M$14M
Investing Cash Flow-$215M-$215M-$37M-$207M$14M
— Financing Activities —
Net Debt Issuance$51M$153M-$174M-$16M-$261M
Stock Repurchased$0-$615K-$466K$0$0
Dividends Paid$0-$50K-$50K-$1M$0
Other Financing$20M$25M-$774K-$17M-$14M
Financing Cash Flow$289M$178M-$176M-$33M-$275M
Net Change in Cash$87M-$14M-$6M$32M$16M
Cash End of Period$234M$219M$208M$240M$255M
Free Cash Flow-$293M-$161M$146M$150M$233M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms